Inventor · disambiguated record
Linghong Xie
Also filed as: XIE LINGHONG
27 granted patents·22 pending applications·175 citations·filing 2001–2024
95Inventor score
Files withNEUROGEN CORP16SUNOVION PHARMACEUTICALS INC15SUMITOMO PHARMA AMERICA INC4XU YUELIAN4LIGAND PHARM INC3
Top patents by PatentIndex Score
49 records- 0191US10196403B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·8 cites·44 claims
- 0291US6949562B2Heterocyclic compounds as ligands of the GABAA receptorPFIZER·Filed 2003·Granted Sep 27, 2005·54 cites·34 claims
- 0391US6653471B2Heterocyclic compounds as ligands of the GABAA receptorNEUROGEN CORP·Filed 2001·Granted Nov 25, 2003·54 cites·27 claims
- 0489US10336732B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·7 cites·20 claims
- 0587US11491133B2Heteroaryl-isochroman compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·2 cites·57 claims
- 0686US10562916B2Substituted quinoxalines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·4 cites·24 claims
- 0786US8969349B2Substituted quinoxalines and quinoxalinones as PDE-10 inhibitorsCAMPBELL JOHN EMMERSON·Filed 2011·Granted Mar 3, 2015·10 cites·25 claims
- 0882US7728009B1Thiazole amides, imidazole amides and related analoguesNEUROGEN CORP·Filed 2006·Granted Jun 1, 2010·6 cites·18 claims
- 0981US2024409550A1Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 1080US10780074B2Compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 22, 2020·2 cites·55 claims
- 1179US9856238B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·2 cites·33 claims
- 1279US7795262B2Piperazinyl oxoalkyl tetrahydroisoquinolines and related analoguesNEUROGEN CORP·Filed 2007·Granted Sep 14, 2010·3 cites·21 claims
- 1375US7851474B2Dipiperazinyl ketones and related analoguesNEUROGEN CORP·Filed 2006·Granted Dec 14, 2010·3 cites·22 claims
- 1473US10927124B2Compounds and compositions and uses thereofPGI DRUG DISCOVERY LLC·Filed 2018·Granted Feb 23, 2021·1 cites·26 claims
- 1573US6982268B2Substituted imidazolylmethyl pyridine and pyrazine derivatives GABAA receptor ligandsNEUROGEN CORP·Filed 2003·Granted Jan 3, 2006·7 cites·20 claims
- 1673US6936617B2Heteroaryl substituted fused bicyclic heteroaryl compound as GABAA receptor ligandsNEUROGEN CORP·Filed 2002·Granted Aug 30, 2005·6 cites·32 claims
- 1773US2022185799A11-heterocyclyl isochromanyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1870US11958862B2Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2021·Granted Apr 16, 2024·0 cites·34 claims
- 1970US8119665B2Aryl imidazoles and related compounds as C5a receptor modulatorsLUKE GEORGE P·Filed 2007·Granted Feb 21, 2012·2 cites·13 claims
- 2069US11192885B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Dec 7, 2021·0 cites·24 claims
- 2163US7271170B2Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligandsNEUROGEN CORP·Filed 2004·Granted Sep 18, 2007·1 cites·190 claims
- 2263US6743817B2Substituted fused pyrroleimines and pyrazoleiminesNEUROGEN CORP·Filed 2001·Granted Jun 1, 2004·2 cites·19 claims
- 2362US6951864B24-imidazol-1-ylmethyl-pyrimidine derivativesNEUROGEN CORP·Filed 2003·Granted Oct 4, 2005·1 cites·24 claims
- 2460US2024245658A1Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2559US2024190835A1Isochroman derivatives and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2658US2024150330A1Chromans and benzofurans as 5-ht1a and taar1 agonistsSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2756US2008139580A1Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligandsNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 2855US2024158416A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUMITOMO PHARMA AMERICA INC·Filed 2022·Application pending·0 cites
- 2955US2024182436A1Substituted sulfonamide-chroman compounds, and pharmaceutical compositions, and methods of use thereofSUMITOMO PHARMA AMERICA INC·Filed 2022·Application pending·0 cites
- 3053US7282498B2Substituted fused pyrroleoximes and fused pyrazoleoximesNEUROGEN CORP·Filed 2004·Granted Oct 16, 2007·0 cites·21 claims
- 3150US2006014746A1Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligandsNEUROGEN CORP·Filed 2005·Application pending·0 cites
- 3250US2008032975A1Substituted Fused Pyrroleoximes and Fused PyrazoleoximesNEUROGEN CORP A CORP OF THE ST·Filed 2007·Application pending·0 cites
- 3349US2010317679A1Substituted aryl-fused spirocyclic aminesLIGAND PHARM INC·Filed 2008·Application pending·0 cites
- 3449US2011002855A1Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analoguesNEUROGEN CORP·Filed 2008·Application pending·0 cites
- 3548US9834564B2Substituted quinolines as PDE-10 inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·0 cites·32 claims
- 3647US9951088B2D2 receptor modulators and methods of use thereof in the treatment of diseases and disordersSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Apr 24, 2018·0 cites·16 claims
- 3747US2008132510A1Imidazolylmethyl and Pyrazolylmethyl Heteroaryl DerivativesHAN BINGSONG·Filed 2006·Application pending·0 cites
- 3846US2008004269A1Pyrazolylmethy Heteroaryl DerivativesXU YUELIAN·Filed 2005·Application pending·0 cites
- 3946US2008247964A1Substituted azaspiro derivativesXU YUELIAN·Filed 2007·Application pending·0 cites
- 4046US2008051387A1Tetrahydropyrido[3,4-d]pyrimidines and related analoguesXU YUELIAN·Filed 2007·Application pending·0 cites
- 4145US7351826B2Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compoundsNEUROGEN CORP·Filed 2004·Granted Apr 1, 2008·0 cites·23 claims
- 4245US7122546B2Imidazol-1-ylmethyl pyridazine derivativesNEUROGEN CORP·Filed 2003·Granted Oct 17, 2006·0 cites·28 claims
- 4345US2019031685A1Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4445US2008167324A1Thiazolymethyl and Oxazolylmethyl Heteroaryl DerivativesXU YUELIAN·Filed 2006·Application pending·0 cites
- 4544US2011082130A1Piperazinyl oxoalkyl tetrahydroisoquinolines and related analoguesLIGAND PHARM INC·Filed 2010·Application pending·0 cites
- 4644US2005148601A1Neurokinin-3 receptor modulators: diaryl imidazole derivativesFiled 2004·Application pending·0 cites
- 4742US2010297035A1Thiazole Amides, Imidazole Amides and Related AnaloguesLIGAND PHARM INC·Filed 2010·Application pending·0 cites
- 4842US2009023737A1Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor LigandsNEUROGEN CORP·Filed 2005·Application pending·0 cites
- 4940US9580409B2Modulators of opioid receptors and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2012·Granted Feb 28, 2017·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Linghong Xie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →